Refers to a compound of formula I, where one of X and y is - N - H and the other one of n = Z1, Z2, Z3, and the other is CH - CR7 Q2, Q3 and Q4 are each CR2 and Cr3, CR4 r1 is Halo, Oh, CN, C1 - C3 alkyl (alkyl, or - C1 - C3), among others R2, R3 and R4 are each h, Halo, - CN, C1 - C3 alkyl, among others ra And RB are each C1 - C3 h, alkyl, or both together to form carbon UNITeS cicloalquileno C3 - C7Heterocicloalquileno 4-6 members RC is H, alkyl C1 - C3 W - C (o) - S (o) - S (o) 2, among others M is C1 - C7 alkyl, cycloalkyl C3 - C7, substituted or unsubstituted by F, Oh, CN, between other R5 is H, alkyl C1 - C3 R7 is H, alkyl, Halo, - CN, C1 - C7, alkyl - or - C1 - C5, among others together they represent - L 1 - 1 - pirrolidincarbonil, metilciclohexilamido ciclopentilsulfamoil -, N, N - carbamoyl - cyclohexylmethyl,Among others. A Preferred Compound is 2 - {2 - Chloro - 5 - [(1 - metilciclohexilamido) phenylamino]} - N - methyl - 5 - 1 - metilbencimidazol ciclopentil - carboxamide n - (4 - bromofenil) - 2 - (2 - Chloro - 5 - [(1 - methyl - metilciclohexilamido) phenylamino]} - 5 - 1 - metilbencimidazol carboxamide among others. These compounds are useful in the treatment of inflammatory diseases and associated conditionsSE REFIERE A UN COMPUESTO DE FORMULA I, DONDE UNO DE X e Y ES -N-H Y EL OTRO -N= UNO DE Z1, Z2, Z3 ES CH Y EL OTRO -CR7 Q2, Q3 Y Q4 SON CADA UNO CR2, CR3, CR4 R1 ES HALO, OH, CN, ALQUILO C1-C3, O-(ALQUILO C1-C3), ENTRE OTROS R2, R3 Y R4 SON CADA UNO H, HALO, -CN, ALQUILO C1-C3, ENTRE OTROS Ra Y Rb SON CADA UNO H, ALQUILO C1-C3, O AMBOS JUNTO AL CARBONO QUE LOS UNE FORMAN CICLOALQUILENO C3-C7, HETEROCICLOALQUILENO DE 4-6-MIEMBROS Rc ES H, ALQUILO C1-C3 W ES -C(O)-, S(O)-, S(O)2, ENTRE OTROS M ES ALQUILO C1-C7, CICLOALQUILO C3-C7, SUSTITUIDOS O NO POR F, OH, CN, ENTRE OTROS R5 ES H, ALQUILO C1-C3 R7 ES H, HALO, -CN, ALQUILO C1-C7, ALQUILO C1-C5-O-, ENTRE OTROS A-L JUNTOS REPRESENTAN 1-PIRROLIDINCARBONIL, 1-METILCICLOHEXILAMIDO, N-CICLOPENTILSULFAMO
